LifeMD (NASDAQ:LFMD) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.15) by 6.67 percent. This is a 166.67 percent decrease over losses of $(0.06) per share from the same period last year. The company reported quarterly sales of $47.300 million which missed the analyst consensus estimate of $49.152 million by 3.77 percent. This is a 23.98 percent decrease over sales of $62.218 million the same period last year.